What is STIM (STIM) stock price today?

STIM (STIM) is currently trading at $2.38, up 5.78% today.

What is STIM P/E ratio?

STIM's P/E ratio is -2.51. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is STIM return on equity (ROE)?

STIM's return on equity (ROE) is -177.27%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is STIM's market cap?

STIM has a market capitalization of $165.62M.

NASDAQ · Medical - Diagnostics & Research

STIM (STIM) Stock

$2.38 +5.78% NASDAQ: STIM Healthcare

Valuation

Metric	Value
Price	$2.38
Market Cap	$165.62M
P/E Ratio	-2.51
P/B Ratio	4.68
P/S Ratio	0.56
EPS (TTM)	$-0.59
52-Week High	$4.85
52-Week Low	$0.80
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-177.27%
ROA	-27.46%
ROCE	-114.81%
Gross Margin	-21.48%
Operating Margin	-20.81%
Net Margin	-24.48%
Debt/Equity	1.82
Current Ratio	2.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$55.0M	$65.0M	$71.0M	$75.0M	$149.0M
Operating Profit	$-28.0M	$-35.0M	$-31.0M	$-35.0M	$-31.0M
Net Profit	$-31.0M	$-37.0M	$-30.0M	$-44.0M	$-39.0M
EPS	$-1.22	$-1.38	$-1.05	$-1.38	$-0.59
Op Margin	-49.8%	-53.9%	-42.8%	-46.1%	-21.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$141.0M	$117.0M	$116.0M	$141.0M	$142.0M
Total Liabilities	$56.0M	$60.0M	$82.0M	$109.0M	$115.0M
Cash	$94.0M	$70.0M	$60.0M	$19.0M	$34.0M
Borrowings	$40.0M	$40.0M	$62.0M	$83.0M	$90.0M

Latest News

Neuronetics Names Nir Naor as CFO MT Newswires · Jul 20, 2026 Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes GlobeNewswire · Jul 20, 2026 Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit Insider Monkey · Jul 14, 2026 Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 GlobeNewswire · Jul 6, 2026 Neuronetics Appoints Robert Greene as Senior Vice President Sales GlobeNewswire · Jun 2, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-28.0M	$-31.0M	$-32.0M	$-31.0M	$-20.0M
Investing Cash Flow	$-12.0M	$3.0M	$-4.0M	$-4.0M	$-2.0M
Financing Cash Flow	$2.0M	$0	$-1.0M	$-4.0M	$-1.0M
Net Cash Flow	$45.0M	$-24.0M	$-11.0M	$-40.0M	$15.0M
Free Cash Flow	$-30.0M	$-34.0M	$-34.0M	$-32.0M	$-21.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-16.06%
Quick Ratio	1.50
Interest Coverage	-3.87
Return 1Y	-54.15%
Return 3Y	-13.24%
Return 5Y	-86.91%

Ownership

Insiders Held33.04%

Institutions Held59.71%

Institutions Float Held89.18%

Institutional Holder	Shares	Report Date
Madryn Asset Management, LP	18,475,893	2026-03-31
UBS Group AG	2,870,598	2026-03-31
Balyasny Asset Management LP	2,743,768	2026-03-31
Blackrock Inc.	2,318,537	2026-03-31
Vanguard Capital Management LLC	2,047,975	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATLN	$0.90	+0.00%	-1.31	$73.17M	0.00%
CATX	$3.00	+1.01%	-2.59	$342.14M	0.00%
CDXS	$1.47	-2.00%	-5.06	$133.62M	0.00%
GNFTGenfit S.A.	$8.95	+4.07%	261.07	$445.68M	0.00%
NYXH	$1.41	-2.76%	-1.23	$55.85M	0.00%

About STIM

STIM is led by CEO Daniel L. Reuvers, employs 716 people, headquartered in US, publicly traded since 2018.

STIM stock trades at $2.38 with a market capitalization of $165.62M. The stock is valued at a price-to-earnings (P/E) ratio of -2.51, price-to-book of 4.68, price-to-sales of 0.56. Over the past 52 weeks the stock has ranged between $0.80 and $4.85, and currently trades 50.9% below its 52-week high.

On profitability, STIM generates a return on equity (ROE) of -177.27%, return on capital employed of -114.81%, an operating margin of -20.81%, a net profit margin of -24.48%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides